Spot the problem

January 19, 1996

Britain's most popular anti-acne drug has rare but potentially serious side effects, according to a report in tomorrow's British Medical Journal. A team which includes researchers from Keele and Leeds universities questions whether the antibiotic minocycline should be used routinely for acne when cheaper and safer treatments are available. Since the drug became widely available in 1972, two patients taking it have died, while 11 cases of severe arthritis and 16 of hepatitis have been reported to the Committee on Safety of Medicines, the article says.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments